CalciMedica, Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for ...

Some habits can make your chronic obstructive pulmonary disease (COPD) worse. Find out which habits to avoid and what to do ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced ...

Insmed remains a Strong Buy as ARIKAYCE, TPIP Phase 3 progress and 44% YoY BRINSUPRI growth drive upside. Click here to read ...

A research group from the Jacobs School of medicine and Biomedical Sciences presented numerous abstracts and earned a scholarship award for the third year in a row at the annual American Thoracic ...

Delve into bronchiectasis, a field long focused on managing symptoms that now has its first targeted treatment with ...

Appointments further strengthen clinical leadership as Medera advances its First-In-Human HFpEF gene therapy program toward key upcoming milestones ...

Here’s what happens during each cycle—and why uninterrupted sleep matters.

CorVista Health, has announced that the American Medical Association (AMA) has granted a new Category III Current Procedural Terminology (CPT®) code for novel augmentative AI algorithmic analysis of ...

APEX 24-week Phase 2 trial is evaluating the safety and efficacy of TX45 in patients with pulmonary hypertension associated with heart failure ...

Super hot, sticky days can be unpleasant for anyone. But for those with certain health conditions, they can pose a more ...

Medera Inc. (“Medera”), a clinical-stage biotechnology company developing disease-modifying gene therapies for cardiovascular disease, today announced that the independent Data Monitoring Committee ...